The Board granted service connection for cervical spine degenerative arthritis and DDD, as well as radiculopathy of both upper extremities and diabetic peripheral neuropathy in both upper extremities. However, the claim for benign prostatic hypertrophy (BPH) was denied.
The deciding factor: The evidence is approximately balanced on whether the Veteran's BPH condition developed over time due to his service or as a result of his exposure to Agent Orange, but it did not manifest in service and there is no direct link to an event or incident during service. The cervical spine degenerative arthritis and DDD, along with radiculopathy and diabetic peripheral neuropathy, were granted based on the evidence supporting their secondary nature to the Veteran's now-service-connected conditions.
- Claimed conditions
- Benign Prostatic Hypertrophy (BPH), Cervical spine degenerative arthritis and degenerative disc disease (DDD), Radiculopathy of the RIGHT upper extremity, Radiculopathy of the LEFT upper extremity, Diabetic peripheral neuropathy of the RIGHT upper extremity, Diabetic peripheral neuropathy of the LEFT upper extremity
- How they argued it
- Not specified
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- March 3, 2025
- Citation
- 25002995
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.